ARDSLEY ADVISORY PARTNERS LP Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$559.0M
Holdings
113
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | NBIXNEUROCRINE BIOSCIENCES INC | 5,000 | $230K | 0.04% | |
| 102 | —TELIGENT INC NEW | 25,000 | $229K | 0.04% | |
| 103 | —ACHAOGEN INC | 10,000 | $217K | 0.04% | |
| 104 | —ZOGENIX INC | 15,000 | $217K | 0.04% | |
| 105 | J40TPROSHARES TR | 6,000 | $215K | 0.04% | |
| 106 | LLYLILLY ELI & CO | 2,500 | $206K | 0.04% | |
| 107 | CERSCERUS CORP | 80,000 | $200K | 0.04% | |
| 108 | RGNXREGENXBIO INC | 10,000 | $197K | 0.04% | |
| 109 | —CARDIOME PHARMA CORP | 40,000 | $180K | 0.03% | |
| 110 | —CAPSTONE TURBINE CORP | 210,000 | $148K | 0.03% | |
| 111 | —AZURRX BIOPHARMA INC | 35,000 | $141K | 0.03% | |
| 112 | ALDXALDEYRA THERAPEUTICS INC | 14,552 | $68K | 0.01% | |
| 113 | —IMPRIMIS PHARMACEUTICALS INC | 20,000 | $64K | 0.01% |
PreviousPage 2 of 2